280 related articles for article (PubMed ID: 33383780)
21. Role of IP3 receptor signaling in cell functions and diseases.
Mikoshiba K
Adv Biol Regul; 2015 Jan; 57():217-27. PubMed ID: 25497594
[TBL] [Abstract][Full Text] [Related]
22. Stimulation of inositol 1,4,5-trisphosphate (IP3) receptor subtypes by adenophostin A and its analogues.
Saleem H; Tovey SC; Riley AM; Potter BV; Taylor CW
PLoS One; 2013; 8(2):e58027. PubMed ID: 23469136
[TBL] [Abstract][Full Text] [Related]
23. The wavy Mutation Maps to the Inositol 1,4,5-Trisphosphate 3-Kinase 2 (IP3K2) Gene of Drosophila and Interacts with IP3R to Affect Wing Development.
Dean DM; Maroja LS; Cottrill S; Bomkamp BE; Westervelt KA; Deitcher DL
G3 (Bethesda); 2015 Nov; 6(2):299-310. PubMed ID: 26613949
[TBL] [Abstract][Full Text] [Related]
24. Ca
Hunt H; Tilūnaitė A; Bass G; Soeller C; Roderick HL; Rajagopal V; Crampin EJ
Biophys J; 2020 Sep; 119(6):1178-1192. PubMed ID: 32871099
[TBL] [Abstract][Full Text] [Related]
25. Comparison of and chromogranin effect on inositol 1,4,5-trisphosphate sensitivity of cytoplasmic and nucleoplasmic inositol 1,4,5-trisphosphate receptor/Ca2+ channels.
Huh YH; Kim KD; Yoo SH
Biochemistry; 2007 Dec; 46(49):14032-43. PubMed ID: 17997581
[TBL] [Abstract][Full Text] [Related]
26. Bcl-2 and FKBP12 bind to IP3 and ryanodine receptors at overlapping sites: the complexity of protein-protein interactions for channel regulation.
Vervliet T; Parys JB; Bultynck G
Biochem Soc Trans; 2015 Jun; 43(3):396-404. PubMed ID: 26009182
[TBL] [Abstract][Full Text] [Related]
27. Creating a New Cancer Therapeutic Agent by Targeting the Interaction between Bcl-2 and IP
Distelhorst CW; Bootman MD
Cold Spring Harb Perspect Biol; 2019 Sep; 11(9):. PubMed ID: 31110129
[TBL] [Abstract][Full Text] [Related]
28. Exploration of inositol 1,4,5-trisphosphate (IP
Chandran A; Chee X; Prole DL; Rahman T
Sci Rep; 2019 Feb; 9(1):2454. PubMed ID: 30792485
[TBL] [Abstract][Full Text] [Related]
29. Targeting Bcl-2-IP3 receptor interaction to reverse Bcl-2's inhibition of apoptotic calcium signals.
Rong YP; Aromolaran AS; Bultynck G; Zhong F; Li X; McColl K; Matsuyama S; Herlitze S; Roderick HL; Bootman MD; Mignery GA; Parys JB; De Smedt H; Distelhorst CW
Mol Cell; 2008 Jul; 31(2):255-65. PubMed ID: 18657507
[TBL] [Abstract][Full Text] [Related]
30. Type 3 IP
Rosa N; Sneyers F; Parys JB; Bultynck G
Int Rev Cell Mol Biol; 2020; 351():101-148. PubMed ID: 32247578
[TBL] [Abstract][Full Text] [Related]
31. Constitutive IP
Bittremieux M; La Rovere RM; Akl H; Martines C; Welkenhuyzen K; Dubron K; Baes M; Janssens A; Vandenberghe P; Laurenti L; Rietdorf K; Morciano G; Pinton P; Mikoshiba K; Bootman MD; Efremov DG; De Smedt H; Parys JB; Bultynck G
Cell Death Differ; 2019 Mar; 26(3):531-547. PubMed ID: 29899382
[TBL] [Abstract][Full Text] [Related]
32. All three IP
Lock JT; Alzayady KJ; Yule DI; Parker I
Sci Signal; 2018 Dec; 11(561):. PubMed ID: 30563861
[TBL] [Abstract][Full Text] [Related]
33. Region-specific proteolysis differentially modulates type 2 and type 3 inositol 1,4,5-trisphosphate receptor activity in models of acute pancreatitis.
Wang L; Wagner LE; Alzayady KJ; Yule DI
J Biol Chem; 2018 Aug; 293(34):13112-13124. PubMed ID: 29970616
[TBL] [Abstract][Full Text] [Related]
34. Inositol 1,4,5-trisphosphate [correction of tris-phosphate] activation of inositol trisphosphate [correction of tris-phosphate] receptor Ca2+ channel by ligand tuning of Ca2+ inhibition.
Mak DO; McBride S; Foskett JK
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15821-5. PubMed ID: 9861054
[TBL] [Abstract][Full Text] [Related]
35. Pathophysiological consequences of isoform-specific IP
Kerkhofs M; Seitaj B; Ivanova H; Monaco G; Bultynck G; Parys JB
Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt B):1707-1717. PubMed ID: 29906486
[TBL] [Abstract][Full Text] [Related]
36. Loss of IP
Tang H; Wang H; Lin Q; Fan F; Zhang F; Peng X; Fang X; Liu J; Ouyang K
J Immunol; 2017 Jul; 199(2):570-580. PubMed ID: 28615414
[TBL] [Abstract][Full Text] [Related]
37. IRBIT suppresses IP3 receptor activity by competing with IP3 for the common binding site on the IP3 receptor.
Ando H; Mizutani A; Kiefer H; Tsuzurugi D; Michikawa T; Mikoshiba K
Mol Cell; 2006 Jun; 22(6):795-806. PubMed ID: 16793548
[TBL] [Abstract][Full Text] [Related]
38. Bcl-xL acts as an inhibitor of IP
Rosa N; Ivanova H; Wagner LE; Kale J; La Rovere R; Welkenhuyzen K; Louros N; Karamanou S; Shabardina V; Lemmens I; Vandermarliere E; Hamada K; Ando H; Rousseau F; Schymkowitz J; Tavernier J; Mikoshiba K; Economou A; Andrews DW; Parys JB; Yule DI; Bultynck G
Cell Death Differ; 2022 Apr; 29(4):788-805. PubMed ID: 34750538
[TBL] [Abstract][Full Text] [Related]
39. Calcium regulation of inositol 1,4,5-trisphosphate receptors.
Joseph SK; Brownell S; Khan MT
Cell Calcium; 2005 Dec; 38(6):539-46. PubMed ID: 16198415
[TBL] [Abstract][Full Text] [Related]
40. Tracing the evolutionary history of Ca
Rosa N; Shabardina V; Ivanova H; Sebé-Pedrós A; Yule DI; Bultynck G
Biochim Biophys Acta Mol Cell Res; 2021 Nov; 1868(12):119121. PubMed ID: 34400171
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
